Tammy Furlong
CHIEF FINANCIAL OFFICER · Elevation Oncology, Inc.
Individual
- 2024
- Jul 23, 2025
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Tammy Furlong's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Larry Robbins - $46.04M in BFLY purchases and sales in the last 12 months
- Michael John Kazley - $45.65M in SDEV purchases and sales in the last 12 months
- R01 Fund LP - $45.65M in SDEV purchases and sales in the last 12 months
- Stephen Hoge - $45.45M in MRNA purchases and sales in the last 12 months
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
- James C. Foster - $43.26M in CRL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Tammy Furlong?
Tammy Furlong is a corporate insider, tracked as CHIEF FINANCIAL OFFICER of Elevation Oncology, Inc. (ELEV). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Tammy Furlong last file a Form 4?
The most recent primary Form 4 on record is dated 23 July 2025, one of 2 filings going back to 2024.
